<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Vtt-Finland on Bioecon</title><link>https://en.bioecon.ru/companies/vtt-finland/</link><description>Recent content in Vtt-Finland on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sat, 25 Jul 2026 20:43:47 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/vtt-finland/index.xml" rel="self" type="application/rss+xml"/><item><title>Sweet proteins (brazzein, thaumatin, monellin)</title><link>https://en.bioecon.ru/technology/sweet-proteins-brazzein-thaumatin-monellin/</link><pubDate>Tue, 07 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/sweet-proteins-brazzein-thaumatin-monellin/</guid><description>Precision fermentation is scaling up intensely sweet, calorie-free plant proteins as sugar replacements — a US platform&amp;rsquo;s third FDA no-questions letter for brazzein, Europe&amp;rsquo;s first commercial-scale brazzein factory under construction in Lithuania, and an Israeli engineered sweet protein clearing FDA GRAS and Singapore approval with published blood-glucose safety data.</description></item></channel></rss>